| Print
aTyr Pharma Inc (ATYR)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Address
3545 John Hopkins Court
Suite No. 250
San Diego
CA
USA
92121
Telephone
+1 858 2231163
Forecast key dates
| Name | Key Date |
|---|---|
| aTyr Pharma Inc Fourth Quarter Earnings Results for 2026 | 2027-03-05T00:00:00 |
| aTyr Pharma Inc Annual Report for 2026 | 2027-03-05T00:00:00 |
| aTyr Pharma Inc Third Quarter Earnings Results for 2026 | 2026-11-06T00:00:00 |
| aTyr Pharma Inc Second Quarter Earnings Results for 2026 | 2026-08-07T00:00:00 |
| aTyr Pharma Inc Annual General Meeting for 2026 | 2026-05-11T09:00:00 |
| aTyr Pharma Inc First Quarter Earnings Results for 2026 | 2026-05-07T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Leerink Partners Global Healthcare Conference | 2026-03-11T08:00:00 |
| aTyr Pharma Inc Annual Report for 2025 | 2026-03-05T00:00:00 |
| aTyr Pharma Inc Fourth Quarter Earnings Results for 2025 | 2026-03-05T00:00:00 |
| aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference 2025 | 2025-12-02T13:00:00 |
| aTyr Pharma Inc Third Quarter Earnings Results for 2025 | 2025-11-06T00:00:00 |
| aTyr Pharma Conference Call | 2025-09-15T08:30:00 |
| aTyr Pharma Inc Second Quarter Earnings Results for 2025 | 2025-08-07T00:00:00 |
| Jefferies Global Healthcare Conference | 2025-06-05T14:00:00 |
| Piper Sandler 3(rd) Annual Virtual Lung Symposium with ATS Takeaways | 2025-05-27T14:00:00 |
| RBC Capital Markets Global Healthcare Conference | 2025-05-21T11:00:00 |
| aTyr Pharma Inc First Quarter Earnings Results for 2025 | 2025-05-07T00:00:00 |
| aTyr Pharma Inc Annual General Meeting for 2025 | 2025-05-01T09:30:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.